Neurological Institute Outcomes

The 30- and 180-day survival rates for infratentorial craniotomy were 100% for 2022.

There has been only 1 death among patients undergoing infratentorial craniotomy at Cleveland Clinic in the past 5 years, which is below the expected number based on national averages. N = number of infratentorial craniotomies performed for brain tumor per year. In 2022 there were 0% inpatient deaths vs an expected mortality of 14.87%.

ᵃThe 3M™ All Patient Refined Diagnosis Related Groups (APR-DRG) Classification System is used for adjusting data for severity of illness and risk of mortality.

Average length of stay has remained lower than predicted during the past 5 years.

Both the 30- and 180-day survival rates for infratentorial craniotomy for glioma were 100% for 2022.

Both the 30- and 180-day survival rates for infratentorial craniotomy for meningioma were 100% for 2022.

In 2022, the 30-day survival rate for infratentorial craniotomy for brain metastasis was 100%; at 180 days, the survival rate was 80%.

Both the 30- and 180-day survival rates for infratentorial craniotomy for Schwannoma were 100% for 2022.